Lung cancer therapeutics that target signaling pathways: an update-Reference-Cited by-同舟云学术

Lung cancer therapeutics that target signaling pathways: an update

Published:2010-10 Issue:5 Volume:4 Page:631-645
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Ray M Roshni,Jablons David,He Biao

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1586/ers.10.64

Reference144 articles.

1. American Cancer Society. Cancer Facts & Figures 2009. American Cancer Society, Atlanta, GA, USA (2009).

2. National Cancer Institute. Non-small cell lung and bronchus cancer (invasive) survival rates, by race, sex, diagnosis year, state and age. SEER Cancer Statistics Review 1975–2004. National Cancer Institute, Bethesda, MD, USA (2008).

3. Cancer statistics, 2000

4. New Combinations in the Treatment of Lung Cancer

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First insight about the ability of specific glycerophospholipids to discriminate non-small cell lung cancer subtypes;Frontiers in Molecular Biosciences;2024-04-25

2. Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer;Pathology - Research and Practice;2023-11

3. Patient-Derived Tumoroid for the Prediction of Radiotherapy and Chemotherapy Responses in Non-Small-Cell Lung Cancer;Biomedicines;2023-06-26

4. The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer;International Journal of Molecular Sciences;2023-01-12

5. CIRCULAR RNAS: NOVEL ACTORS OF WNT SIGNALING PATHWAY IN LUNG CANCER PROGRESSION;EXCLI J;2023